Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
403 | 3 | PARAGANGLIOMA//PHEOCHROMOCYTOMA//NEUROBLASTOMA | 31272 |
965 | 2 | PARAGANGLIOMA//NEUROBLASTOMA//PHEOCHROMOCYTOMA | 10987 |
12427 | 1 | I 131 MIBG//METAIODOBENZYLGUANIDINE//MIBG | 937 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | I 131 MIBG | authKW | 1245824 | 6% | 71% | 52 |
2 | METAIODOBENZYLGUANIDINE | authKW | 831600 | 7% | 36% | 68 |
3 | MIBG | authKW | 552432 | 7% | 26% | 62 |
4 | I 131 METAIODOBENZYLGUANIDINE | authKW | 374355 | 2% | 70% | 16 |
5 | NEUROBLASTOMA | authKW | 320781 | 24% | 4% | 229 |
6 | 3 IODOBENZYLGUANIDINE | authKW | 235427 | 1% | 50% | 14 |
7 | MIBG SCAN | authKW | 164804 | 1% | 70% | 7 |
8 | I 131 MIBG THERAPY | authKW | 149821 | 1% | 64% | 7 |
9 | 131 I METAIODOBENZYLGUANIDINE | authKW | 107628 | 0% | 80% | 4 |
10 | MIBG THERAPY | authKW | 105104 | 1% | 63% | 5 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Radiology, Nuclear Medicine & Medical Imaging | 18057 | 53% | 0% | 500 |
2 | Oncology | 2143 | 26% | 0% | 244 |
3 | Pediatrics | 1320 | 14% | 0% | 128 |
4 | Hematology | 107 | 4% | 0% | 38 |
5 | Nuclear Science & Technology | 60 | 3% | 0% | 29 |
6 | Medicine, General & Internal | 37 | 5% | 0% | 44 |
7 | MEDICINE, MISCELLANEOUS | 19 | 0% | 0% | 1 |
8 | Chemistry, Inorganic & Nuclear | 13 | 2% | 0% | 23 |
9 | Chemistry, Medicinal | 11 | 2% | 0% | 17 |
10 | Biochemical Research Methods | 11 | 2% | 0% | 20 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | TARGETED THER Y GRP | 102997 | 1% | 44% | 7 |
2 | W GLASGOW HOSP UNIV TRUST | 100903 | 0% | 100% | 3 |
3 | GLASGOW CANC STUDIES | 67269 | 0% | 100% | 2 |
4 | SEMONOV | 67269 | 0% | 100% | 2 |
5 | CANC UNITED KINGDOM BEATSON S | 44844 | 0% | 67% | 2 |
6 | ABRAMSON PEDIAT 902A ONCOL | 33634 | 0% | 100% | 1 |
7 | ABT SAUERSTOFFUBERDRUCK MED | 33634 | 0% | 100% | 1 |
8 | ANTONI VAN LEEUWENHOEKHUIS NUCL MED | 33634 | 0% | 100% | 1 |
9 | BIOL VIA ORAZIO RAIMONDO 1 | 33634 | 0% | 100% | 1 |
10 | CANC B1208 PEDIAT HEMATOL ONCOL | 33634 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | NUC COMPACT-EUROPEAN-AMERICAN COMMUNICATIONS IN NUCLEAR MEDICINE | 23082 | 1% | 5% | 13 |
2 | MEDICAL AND PEDIATRIC ONCOLOGY | 21490 | 4% | 2% | 40 |
3 | JOURNAL OF NUCLEAR MEDICINE | 20325 | 8% | 1% | 79 |
4 | CLINICAL NUCLEAR MEDICINE | 18065 | 6% | 1% | 60 |
5 | NUKLEARMEDIZINER | 14432 | 1% | 5% | 8 |
6 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 12699 | 4% | 1% | 35 |
7 | QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 11599 | 1% | 2% | 14 |
8 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 7821 | 3% | 1% | 28 |
9 | SEMINARS IN NUCLEAR MEDICINE | 7626 | 2% | 1% | 17 |
10 | NUCLEAR MEDICINE COMMUNICATIONS | 7589 | 3% | 1% | 31 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | I 131 MIBG | 1245824 | 6% | 71% | 52 | Search I+131+MIBG | Search I+131+MIBG |
2 | METAIODOBENZYLGUANIDINE | 831600 | 7% | 36% | 68 | Search METAIODOBENZYLGUANIDINE | Search METAIODOBENZYLGUANIDINE |
3 | MIBG | 552432 | 7% | 26% | 62 | Search MIBG | Search MIBG |
4 | I 131 METAIODOBENZYLGUANIDINE | 374355 | 2% | 70% | 16 | Search I+131+METAIODOBENZYLGUANIDINE | Search I+131+METAIODOBENZYLGUANIDINE |
5 | NEUROBLASTOMA | 320781 | 24% | 4% | 229 | Search NEUROBLASTOMA | Search NEUROBLASTOMA |
6 | 3 IODOBENZYLGUANIDINE | 235427 | 1% | 50% | 14 | Search 3+IODOBENZYLGUANIDINE | Search 3+IODOBENZYLGUANIDINE |
7 | MIBG SCAN | 164804 | 1% | 70% | 7 | Search MIBG+SCAN | Search MIBG+SCAN |
8 | I 131 MIBG THERAPY | 149821 | 1% | 64% | 7 | Search I+131+MIBG+THERAPY | Search I+131+MIBG+THERAPY |
9 | 131 I METAIODOBENZYLGUANIDINE | 107628 | 0% | 80% | 4 | Search 131+I+METAIODOBENZYLGUANIDINE | Search 131+I+METAIODOBENZYLGUANIDINE |
10 | MIBG THERAPY | 105104 | 1% | 63% | 5 | Search MIBG+THERAPY | Search MIBG+THERAPY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |